[{"id":"0d569526-0a1b-477a-bbb0-9fbb8b295214","acronym":"ARCADIAN","url":"https://clinicaltrials.gov/study/NCT04648033","created_at":"2021-01-19T20:40:00.018Z","updated_at":"2024-07-02T16:34:25.606Z","phase":"Phase 1","brief_title":"Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC","source_id_and_acronym":"NCT04648033 - ARCADIAN","lead_sponsor":"University of Oxford","biomarkers":" MIR210","pipe":"","alterations":" ","tags":["MIR210"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • vinorelbine tartrate • atovaquone"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 12/07/2020","start_date":" 12/07/2020","primary_txt":" Primary completion: 10/02/2023","primary_completion_date":" 10/02/2023","study_txt":" Completion: 10/02/2023","study_completion_date":" 10/02/2023","last_update_posted":"2024-06-17"},{"id":"202a63d1-07ad-43e6-b0e5-90f62602468d","acronym":"","url":"https://clinicaltrials.gov/study/NCT04149613","created_at":"2021-01-18T20:15:40.071Z","updated_at":"2024-07-02T16:36:07.094Z","phase":"","brief_title":"Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer","source_id_and_acronym":"NCT04149613","lead_sponsor":"American University of Beirut Medical Center","biomarkers":" MIR155 • MIR200B • MIR21 • MIR200C • MIR126 • MIR210 • MIR31 • CRP • MIR19A • MIR203A • MIR29A • MIR345","pipe":"","alterations":" ","tags":["MIR155 • MIR200B • MIR21 • MIR200C • MIR126 • MIR210 • MIR31 • CRP • MIR19A • MIR203A • MIR29A • MIR345"],"overall_status":"Enrolling by invitation","enrollment":" Enrollment 100","initiation":"Initiation: 05/25/2018","start_date":" 05/25/2018","primary_txt":" Primary completion: 12/18/2023","primary_completion_date":" 12/18/2023","study_txt":" Completion: 04/18/2024","study_completion_date":" 04/18/2024","last_update_posted":"2022-07-20"},{"id":"3f2f3d31-4d62-4535-a44f-21670145cf7d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01248637","created_at":"2021-01-18T05:01:47.004Z","updated_at":"2024-07-02T16:37:08.502Z","phase":"","brief_title":"Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole","source_id_and_acronym":"NCT01248637","lead_sponsor":"University Health Network, Toronto","biomarkers":" SPP1 • MIR210","pipe":"","alterations":" ","tags":["SPP1 • MIR210"],"overall_status":"Completed","enrollment":" Enrollment 200","initiation":"Initiation: 10/01/2010","start_date":" 10/01/2010","primary_txt":" Primary completion: 12/01/2017","primary_completion_date":" 12/01/2017","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2018-07-30"}]